Skip to main content
. 2020 Oct 6;11(40):3660–3674. doi: 10.18632/oncotarget.27747

Figure 4. Cellular response to single agent treatments with carboplatin, simvastatin or CID-1067700 or combinations thereof.

Figure 4

Immunoblot analysis of single agent treatment in (A) JHOC-5; (B) OVMANA; (C) TOV-21G. Immunoblots were done at least three times for consistency for p-ERK, ERK, p-AKT and AKT. Immunoblots for p62 and LC3A/B-I/II were performed twice for single agent treatments and once for combination treatments. NB a small air bubble partially obscuring an unspecific band in the p-AKT blot in the OVMANA cell line does not affect the interpretation of the result.